There is clear support from the literature for a role of exocrine pancreas pathology/dysfunction on insulin release, best illustrated by the fact that CF patients with pancreatic insufficiency have a greater deficit in insulin and glucagon release vs. those with residual exocrine pancreatic function (10, 13, 14). The gene discussed is INS; the disease is exocrine pancreatic insufficiency.